{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T09:20:07Z","timestamp":1777368007735,"version":"3.51.4"},"reference-count":22,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2004,2,27]],"date-time":"2004-02-27T00:00:00Z","timestamp":1077840000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Eye"],"published-print":{"date-parts":[[2004,9]]},"DOI":"10.1038\/sj.eye.6701353","type":"journal-article","created":{"date-parts":[[2004,3,5]],"date-time":"2004-03-05T10:23:06Z","timestamp":1078482186000},"page":"905-910","source":"Crossref","is-referenced-by-count":24,"title":["Short-term ocular tolerability of dorzolamide 2% and brinzolamide 1% vs placebo in primary open-angle glaucoma and ocular hypertension subjects"],"prefix":"10.1038","volume":"18","author":[{"given":"W C","family":"Stewart","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D G","family":"Day","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J A","family":"Stewart","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"K T","family":"Holmes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J N","family":"Jenkins","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2004,2,27]]},"reference":[{"key":"BF6701353_CR1","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1001\/archopht.1992.01080160073033","volume":"110","author":"EA Lippa","year":"1992","unstructured":"Lippa EA, Carlson LE, Ehinger B, Eriksson LO, Finnstrom K, Holmin C et al. Dose response and duration of action of dorzolamide, a topical carbonic anhydrase inhibitor. Arch Ophthalmol 1992; 110: 495.","journal-title":"Arch Ophthalmol"},{"key":"BF6701353_CR2","doi-asserted-by":"publisher","first-page":"308","DOI":"10.1016\/S0161-6420(91)32295-4","volume":"98","author":"EA Lippa","year":"1991","unstructured":"Lippa EA, Schuman JS, Higginbotham EJ, Kass MA, Weinrib RN, Skuta GL et al. MK-507 versus sezolamide: a comparative efficacy of two topically active carbonic anhydrase inhibitors. Ophthalmology 1991; 98(3): 308.","journal-title":"Ophthalmology"},{"key":"BF6701353_CR3","doi-asserted-by":"publisher","first-page":"1343","DOI":"10.1001\/archopht.1993.01090100051026","volume":"111","author":"M Wilkerson","year":"1993","unstructured":"Wilkerson M, Cyrlin M, Lippa EA, Esposito D, Deasy D, Panebianco D et al. Four-week safety and efficacy study of dorzolamide, a novel, active topical carbonic anhydrase inhibitor. Arch Ophthalmol 1993; 111: 1343.","journal-title":"Arch Ophthalmol"},{"key":"BF6701353_CR4","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1097\/00061198-199400340-00002","volume":"3","author":"Y Kitazawa","year":"1994","unstructured":"Kitazawa Y, Azuma I, Iwata K, Tsukahara S, Shioes Y, Araie M et al. Dorzolamide, a topical carbonic anhydrase inhibitor: a two-week dose response study in patients with glaucoma or ocular hypertension. J Glaucoma 1994; 3: 275\u2013279.","journal-title":"J Glaucoma"},{"key":"BF6701353_CR5","doi-asserted-by":"publisher","first-page":"1009","DOI":"10.1001\/archopht.1995.01100080061030","volume":"113","author":"E Strahlman","year":"1995","unstructured":"Strahlman E, Tipping R, Vogel R, the International Dorzolamide Study Group. A double masked, randomized 1-year study comparing dorzolamide (Trusopt), timolol, and betaxolol. Arch Ophthalmol 1995; 113: 1009\u20131016.","journal-title":"Arch Ophthalmol"},{"key":"BF6701353_CR6","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1097\/00061198-199510000-00002","volume":"4","author":"R Laibovitz","year":"1995","unstructured":"Laibovitz R, Strahlman ER, Barber BL, Strohmaier KM . Comparison of quality of life and patient preference of dorzolamide and pilocarpine as adjunctive therapy to timolol in the treatment of glaucoma. J Glaucoma 1995; 4: 306\u2013313.","journal-title":"J Glaucoma"},{"key":"BF6701353_CR7","first-page":"2605","volume":"38","author":"DH Shin","year":"1997","unstructured":"Shin DH, the Brinzolamide Adjunctive Therapy Study Group. A triple-masked, placebo-controlled, adjunctive therapy study of the efficacy and safety of TID-dosed brinzolamide 1.0% compared to TID-dosed placebo when used adjunctively to timolol 0.5%. Invest Ophthalmol Vis Sci (Suppl) 1997; 38: 2605.","journal-title":"Invest Ophthalmol Vis Sci (Suppl)"},{"key":"BF6701353_CR8","first-page":"2605","volume":"38","author":"CB Camras","year":"1997","unstructured":"Camras CB, the Brinzolamide Primary Therapy Study Group. A triple-masked, primary therapy study of the efficacy and safety of BID and TID-dosed brinzolamide 1% compared to TID-dosed dorzolamide 2% and BID-dosed timolol 0.5%. Invest Ophthalmol Vis Sci (Suppl) 1997; 38: 2605.","journal-title":"Invest Ophthalmol Vis Sci (Suppl)"},{"key":"BF6701353_CR9","first-page":"2603","volume":"38","author":"R Stewart","year":"1997","unstructured":"Stewart R, the Brinzolamide Comfort Study Group. The ocular comfort of the TID-dosed brinzolamide 1.0% compared to TID-dosed dorzolamide 2.0% in patients with primary open-angle glaucoma or ocular hypertension. Invest Ophthalmol Vis Sci (Suppl) 1997; 38: 2603.","journal-title":"Invest Ophthalmol Vis Sci (Suppl)"},{"key":"BF6701353_CR10","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1002\/j.1552-4604.1985.tb02827.x","volume":"25","author":"B Scoville","year":"1985","unstructured":"Scoville B, Krieglstein GK, Then E, Yokoyama S, Yokoyama T . Measuring drug-induced eye irritation: a simple new clinical assay. J Clin Pharmacol 1985; 25: 210\u2013218.","journal-title":"J Clin Pharmacol"},{"key":"BF6701353_CR11","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1016\/0304-3959(83)90126-4","volume":"17","author":"DD Price","year":"1983","unstructured":"Price DD, McGrath PA, Rafii A, Buckingham B . The validation of visual analogue scales as ratio scale measures for chronic and experimental pain. Pain 1983; 17: 45\u201356.","journal-title":"Pain"},{"key":"BF6701353_CR12","volume-title":"Essentials of Statistics","author":"SA Book","year":"1978","unstructured":"Book SA . Essentials of Statistics. McGraw Hill Book Company: New York, 1978, pp 117\u2013122, 205\u2013215."},{"key":"BF6701353_CR13","first-page":"336","volume-title":"Fundamentals of Biostatistics","author":"B Rosner","year":"1982","unstructured":"Rosner B . Fundamentals of Biostatistics. Duxbury Press: Boston, 1982, pp 336\u2013341."},{"key":"BF6701353_CR14","first-page":"63","volume-title":"Nonparametric Statistics for the Behavioral Sciences","author":"S Siegel","year":"1956","unstructured":"Siegel S . Nonparametric Statistics for the Behavioral Sciences. McGraw Hill Book Company: New York, 1956, pp 63\u201367."},{"key":"BF6701353_CR15","doi-asserted-by":"publisher","first-page":"400","DOI":"10.1016\/S0002-9394(98)00095-6","volume":"126","author":"LH Silver","year":"1988","unstructured":"Silver LH, the Brinzolamide Primary Therapy Study Group. Clinical efficacy and safety of brinzolamide (Azopt\u2122), a new topical carbonic anhydrase inhibitor for primary open-angle glaucoma and ocular hypertension. Am J Ophthalmol 1988; 126: 400\u2013408.","journal-title":"Am J Ophthalmol"},{"key":"BF6701353_CR16","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1016\/S0002-9394(01)00974-6","volume":"132","author":"JE Michaud","year":"2001","unstructured":"Michaud JE, Friren B, the International Brinzolamide Adjunctive Study Group. Comparison of topical brinzolamide 1% and dorzolamide 2% eye drops given twice daily in addition to timolol 0.5% in patients with primary open-angle glaucoma or ocular hypertension. Am J Ophthalmol 2001; 132: 235\u2013243.","journal-title":"Am J Ophthalmol"},{"key":"BF6701353_CR17","doi-asserted-by":"publisher","first-page":"1204","DOI":"10.1016\/S0149-2918(00)83063-5","volume":"22","author":"H Barnebey","year":"2000","unstructured":"Barnebey H, Kwok SY . Patients' acceptance of a switch from dorzolamide to brinzolamide for the treatment of glaucoma in a clinical practice setting. Clin Ther 2000; 22: 1204\u20131212.","journal-title":"Clin Ther"},{"key":"BF6701353_CR18","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1038\/clpt.1983.159","volume":"34","author":"K Sriwatanakul","year":"1983","unstructured":"Sriwatanakul K, Kelvie W, Lasagna L, Calimlim JF, Weis OF, Mehta G . Studies with different types of visual analog scales for measurement of pain. Clin Pharmacol Ther 1983; 34(2): 234\u2013239.","journal-title":"Clin Pharmacol Ther"},{"key":"BF6701353_CR19","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1016\/S0304-3959(97)00005-5","volume":"72","author":"SL Collins","year":"1997","unstructured":"Collins SL, Moore RA, McQuay HJ . The visual analogue pain intensity scale: what is moderate pain in millimeters? Pain 1997; 72(1\u20132): 95\u201397.","journal-title":"Pain"},{"key":"BF6701353_CR20","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1016\/S0099-2399(06)80038-5","volume":"20","author":"P Curtis","year":"1994","unstructured":"Curtis P, Gartman LA, Green DB . Utilization of ketorolac tromethanine for control of severe odontogenic pain. J Endod 1994; 20(9): 457\u2013459.","journal-title":"J Endod"},{"key":"BF6701353_CR21","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1046\/j.1365-2125.1996.34015.x","volume":"41","author":"RA Seymour","year":"1996","unstructured":"Seymour RA, Kelly PJ, Hawesford JE . The efficacy of ketoprofen and paracetamol (acetaminophen) in postoperative pain after third molar surgery. Br J Clin Pharmacol 1996; 41: 581\u2013585.","journal-title":"Br J Clin Pharmacol"},{"key":"BF6701353_CR22","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1016\/0304-3959(95)00056-X","volume":"62","author":"A Stubhaug","year":"1995","unstructured":"Stubhaug A, Grimstad J, Breivik H . Lack of analgestic effect of 50 and 100\u2009mg oral tramadol after orthopedic surgery: a randomized, double-blind, placebo and standard active drug comparison. Pain 1995; 62(1): 111\u2013118.","journal-title":"Pain"}],"container-title":["Eye"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/6701353.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/6701353","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/6701353.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,18]],"date-time":"2023-05-18T12:16:04Z","timestamp":1684412164000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/6701353"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,2,27]]},"references-count":22,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2004,9]]}},"alternative-id":["BF6701353"],"URL":"https:\/\/doi.org\/10.1038\/sj.eye.6701353","relation":{},"ISSN":["0950-222X","1476-5454"],"issn-type":[{"value":"0950-222X","type":"print"},{"value":"1476-5454","type":"electronic"}],"subject":[],"published":{"date-parts":[[2004,2,27]]}}}